<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04160169</url>
  </required_header>
  <id_info>
    <org_study_id>18-1049</org_study_id>
    <nct_id>NCT04160169</nct_id>
  </id_info>
  <brief_title>Counseling on Injectable Contraception and HIV Risk in Tanzania</brief_title>
  <official_title>Counseling on Injectable Contraception and HIV Risk: Evaluation of a Pilot Intervention in Tanzania</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of North Carolina, Chapel Hill</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>United States Agency for International Development (USAID)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ministry of Health, Tanzania</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Johns Hopkins Bloomberg School of Public Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of North Carolina, Chapel Hill</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the evaluation was to assess the effect of providing injectable and HIV
      risk counseling messages on contraceptive knowledge and behavior during a three month pilot
      intervention in ten healthcare facilities in Tanzania.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The evaluation assessed the effect of providing injectable and HIV risk counseling messages
      on contraceptive knowledge and uptake during a three month pilot intervention. The
      intervention was conducted September-November 2018 in ten healthcare facilities located in
      the Iringa and Njombe regions of Tanzania. Data collection for the evaluation occurred
      November-December 2018 and included 471 client exit interviews, 26 healthcare provider
      interviews, and the extraction of monthly aggregate service statistics for 12 months prior to
      the intervention and three months of the intervention. Univariate and bivariate analyses were
      used to assess quantitative interview data. Thematic qualitative assessment was used to
      assess qualitative interview data from healthcare providers. Interrupted time series analysis
      was used to assess changes in the trend of monthly contraceptive uptake.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2018</start_date>
  <completion_date type="Actual">November 30, 2018</completion_date>
  <primary_completion_date type="Actual">November 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of clients obtaining an injectable during their family planning appointment</measure>
    <time_frame>After implementation of counseling messages, up to 13 weeks</time_frame>
    <description>Injectable uptake of interviewed clients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent of clients obtaining an injectable during their family planning appointment</measure>
    <time_frame>After implementation of counseling messages, up to 13 weeks</time_frame>
    <description>Injectable uptake of interviewed clients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Monthly total number of family planning clients by method obtained</measure>
    <time_frame>September 2017 through November 2018</time_frame>
    <description>Contraceptive uptake during pilot intervention</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of correct hormonal contraception and HIV risk counseling messages mentioned during spontaneous recall</measure>
    <time_frame>After implementation of counseling messages, up to 13 weeks</time_frame>
    <description>Knowledge of hormonal contraception and HIV risk messages</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of correct hormonal contraception and HIV risk counseling messages mentioned during spontaneous recall</measure>
    <time_frame>After implementation of counseling messages, up to 13 weeks</time_frame>
    <description>Knowledge of hormonal contraception and HIV risk messages</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of correct True/False statements on hormonal contraception and HIV (11 total)</measure>
    <time_frame>After implementation of counseling messages, up to 13 weeks</time_frame>
    <description>Knowledge of hormonal contraception and HIV risk messages</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of correct True/False statements on hormonal contraception and HIV (11 total)</measure>
    <time_frame>After implementation of counseling messages, up to 13 weeks</time_frame>
    <description>Knowledge of hormonal contraception and HIV risk messages</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of interviewed clients reporting an intention to use condoms as a dual method</measure>
    <time_frame>After implementation of counseling messages, up to 13 weeks</time_frame>
    <description>Intention to use condoms as a dual method</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent of interviewed clients reporting an intention to use condoms as a dual method</measure>
    <time_frame>After implementation of counseling messages, up to 13 weeks</time_frame>
    <description>Intention to use condoms as a dual method</description>
  </secondary_outcome>
  <enrollment type="Actual">10</enrollment>
  <condition>Contraception</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Counseling messages on injectable use and HIV acquisition risk</intervention_name>
    <description>Counseling messages based on 2017 World Health Organization guidance, a review of the Strategic Communication Framework for Hormonal Contraceptive Methods and Potential HIV-related Risks, and the Family Planning Global Handbook were provided to clients expressing interest in injectables during regular family planning appointments.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All women attending a participating healthcare facility during the three month intervention
        period and who met eligibility criteria received the hormonal contraception and HIV risk
        messages.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Expressed interest in injectable use

          -  HIV-negative or unknown HIV status

        Exclusion Criteria:

          -  Positive HIV status known to healthcare provider
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>49 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Janine Barden-O'Fallon, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina, Chapel Hill</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ilula Hospital</name>
      <address>
        <city>Ilula</city>
        <state>Iringa</state>
        <country>Tanzania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mafinga Hospital</name>
      <address>
        <city>Mafinga</city>
        <state>Iringa</state>
        <country>Tanzania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ihongole Health Center</name>
      <address>
        <city>Iringa</city>
        <country>Tanzania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ipogolo Health Center</name>
      <address>
        <city>Iringa</city>
        <country>Tanzania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kimande Health Center</name>
      <address>
        <city>Iringa</city>
        <country>Tanzania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ipelele Health Center</name>
      <address>
        <city>Njombe</city>
        <country>Tanzania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kibena Regional Referral Hospital</name>
      <address>
        <city>Njombe</city>
        <country>Tanzania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Makambako Hospital</name>
      <address>
        <city>Njombe</city>
        <country>Tanzania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Makete Hospital</name>
      <address>
        <city>Njombe</city>
        <country>Tanzania</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Njombe Health Center</name>
      <address>
        <city>Njombe</city>
        <country>Tanzania</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tanzania</country>
  </location_countries>
  <link>
    <url>http://apps.who.int/iris/bitstream/handle/10665/254662/WHO-RHR-17.04-eng.pdf;jsessionid=035D4751CFD8B1A20F3DF079DD896C81?sequence=1</url>
    <description>Hormonal contraceptive eligibility for women at high risk of HIV: Guidance statement. 2017</description>
  </link>
  <link>
    <url>http://healthcommcapacity.org/hc3resources/strategic-communication-framework-for-hormonal-contraceptive-methods-and-potential-hiv-related-risks/</url>
    <description>Strategic communication framework for hormonal contraceptive methods and potential HIV-related risks. 2017.</description>
  </link>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 7, 2019</study_first_submitted>
  <study_first_submitted_qc>November 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 12, 2019</study_first_posted>
  <last_update_submitted>November 8, 2019</last_update_submitted>
  <last_update_submitted_qc>November 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Counseling</keyword>
  <keyword>Tanzania</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Deidentified data from the client interviews are publicly available through MEASURE Evaluation Dataverse in STATA format. The study report is also available on Dataverse.</ipd_description>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Data are currently available and will remain on Dataverse.org</ipd_time_frame>
    <ipd_access_criteria>Site registration required.</ipd_access_criteria>
    <ipd_url>https://dataverse.unc.edu/dataset.xhtml?persistentId=doi:10.15139/S3/XEXQXO</ipd_url>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_id>doi:10.15139/S3/XEXQXO</doc_id>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>https://dataverse.unc.edu/dataset.xhtml?persistentId=doi:10.15139/S3/XEXQXO</doc_url>
    </study_doc>
  </study_docs>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

